TrkA expression directs the anti-neoplastic activity of MLK3 inhibitors in triple-negative breast cancer.
Nair RS, Kumar S, Das S, Singh SK, Srivastava P, Sondarva G, Rao A, Sinha SC, Xiong R, Bloem L, Hoskins K, Thatcher GRJ, Rana B, Rana A.
Nair RS, et al. Among authors: hoskins k.
Oncogene. 2023 Mar;42(14):1132-1143. doi: 10.1038/s41388-023-02633-6. Epub 2023 Feb 22.
Oncogene. 2023.
PMID: 36813855